| Inherited breast cancer in Nigerian women Y Zheng, T Walsh, S Gulsuner, S Casadei, MK Lee, TO Ogundiran, ... Journal of clinical oncology 36 (28), 2820-2825, 2018 | 109 | 2018 |
| Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features JJ Pitt, M Riester, Y Zheng, TF Yoshimatsu, A Sanni, O Oluwasola, ... Nature communications 9 (1), 4181, 2018 | 101 | 2018 |
| Evaluation of prescription pattern in Osun state (Southwest) Nigeria CP Babalola, SA Awoleye, JO Akinyemi, OA Kotila J Public Health Epidemiol 3 (3), 94-98, 2011 | 90 | 2011 |
| Therapeutic potentials of antiviral plants used in traditional african medicine with COVID-19 in focus: a Nigerian perspective AF Attah, AA Fagbemi, O Olubiyi, H Dada-Adegbola, A Oluwadotun, ... Frontiers in pharmacology 12, 596855, 2021 | 73 | 2021 |
| Broadening participation in the sciences within and from Africa: Purpose, challenges, and prospects IN Okeke, CP Babalola, DK Byarugaba, A Djimde, OR Osoniyi CBE—Life Sciences Education 16 (2), es2, 2017 | 70 | 2017 |
| COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa B Bright, CP Babalola, NA Sam-Agudu, AA Onyeaghala, A Olatunji, ... Globalization and health 17, 1-14, 2021 | 61 | 2021 |
| Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs) CT Ong, CP Babalola, CH Nightingale, DP Nicolau Journal of Antimicrobial Chemotherapy 56 (3), 498-501, 2005 | 54 | 2005 |
| Effects of absorption enhancers in chloroquine suppository formulations: I: In vitro release characteristics CO Onyeji, AS Adebayo, CP Babalola European journal of pharmaceutical sciences 9 (2), 131-136, 1999 | 39 | 1999 |
| Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women B Adedokun, Z Du, G Gao, TU Ahearn, KL Lunetta, G Zirpoli, J Figueroa, ... Nature communications 12 (1), 4198, 2021 | 36 | 2021 |
| Pharmacokinetic, pharmacogenetic, and other factors influencing CNS penetration of antiretrovirals JN Nwogu, Q Ma, CP Babalola, WA Adedeji, GD Morse, B Taiwo AIDS Research and Treatment 2016 (1), 2587094, 2016 | 33 | 2016 |
| Pharmacokinetics of quinine in African patients with acute falciparum malaria. CP Babalola, OO Bolaji, FA Ogunbona, A Sowunmi, O Walker Pharmacy World and Science 20, 118-122, 1998 | 33 | 1998 |
| Effects of antifolates-co-trimoxazole and pyrimethamine-sulfadoxine-on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria A Sowunmi, BA Fateye, AA Adedeji, FA Fehintola, AE Bamgboye, ... Memorias do Instituto Oswaldo Cruz 100, 451-455, 2005 | 32 | 2005 |
| Simultaneous spectrophotometric determination of trimethoprim and sulphamethoxazole following charge-transfer complexation with chloranilic acid OA Adegoke, CP Babalola, OA Kotila, O Obuebhor Arabian Journal of Chemistry 10, S3848-S3860, 2017 | 31 | 2017 |
| Medical Herbalism and Clinical Research: A Global Perspective. GKS Ameh SJ, Obodozie OO, Babalola CP British Journal of Pharmaceutical Research 1 (4), 99-123, 2011 | 31* | 2011 |
| Column liquid chromatographic analysis of quinine in human plasma, saliva and urine CP Babalola, OO Bolaji, PAF Dixon, FA Ogunbona Journal of Chromatography B: Biomedical Sciences and Applications 616 (1 …, 1993 | 31 | 1993 |
| Pharmacodynamic Profile of Ertapenem against Klebsiella pneumoniae and Escherichia coli in a Murine Thigh Model D Maglio, MA Banevicius, C Sutherland, C Babalola, CH Nightingale, ... Antimicrobial agents and chemotherapy 49 (1), 276-280, 2005 | 29 | 2005 |
| Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes N Ansari-Pour, Y Zheng, TF Yoshimatsu, A Sanni, M Ajani, JB Reynier, ... Nature communications 12 (1), 6946, 2021 | 28 | 2021 |
| Neo‐adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource‐poor setting (Nigeria): efficacy and safety in a phase II … OA Arowolo, UO Njiaju, TO Ogundiran, O Abidoye, OO Lawal, M Obajimi, ... The breast journal 19 (5), 470-477, 2013 | 27 | 2013 |
| Determination of the physicochemical properties of pyronaridine-a new antimalarial drug OA Adegoke, CP Babalola, OS Oshitade, AA Famuyiwa Pak J Pharm Sci 19 (1), 1-6, 2006 | 25 | 2006 |
| Polymorphic oxidative metabolism of proguanil in a Nigerian population O Bolaji, I Sadare, C Babalola, F Ogunbona European journal of clinical pharmacology 58, 543-545, 2002 | 25 | 2002 |
olayinka adejoke kotilaDoctor of Pharmaceutical Chemistry, University of Ibadan在 mail.ui.edu.ng 的电子邮件经过验证
